Does Nasal Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) Prevent Deep Surgical Site Infections for Elective Cervical Spinal Fusion?

Xiong, Grace X; Greene, Nattaly E; Hershman, Stuart H; Fogel, Harold A; Schwab, Joseph H; Bono, Christopher M; Tobert, Daniel G

Xiong, Grace X; Greene, Nattaly E; Hershman, Stuart H; Fogel, Harold A; Schwab, Joseph H; Bono, Christopher M; Tobert, Daniel G.

Affiliation

Xiong GX; Harvard Combined Orthopaedic Residency Program.
Greene NE; Harvard Combined Orthopaedic Residency Program.
Hershman SH; Massachusetts General Hospital, Boston, MA.
Fogel HA; Massachusetts General Hospital, Boston, MA.
Schwab JH; Massachusetts General Hospital, Boston, MA.
Bono CM; Massachusetts General Hospital, Boston, MA.
Tobert DG; Massachusetts General Hospital, Boston, MA.

Clin Spine Surg ; 36(1): E51-E58, 2023 02 01.

Article in En | MEDLINE | ID: mdl-35676748

Subject(s)

Methicillin-Resistant Staphylococcus aureus; Spinal Fusion; Adult; Humans; Vancomycin/therapeutic use; Surgical Wound Infection/etiology; Retrospective Studies; Spinal Fusion/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spinal Fusion / Methicillin-Resistant Staphylococcus aureus Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Humans Language: En Journal: Clin Spine Surg Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google